BIIB067

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	19

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 10 of 19 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004590-51-IT (EUCTR)	24/01/2022	07/06/2021	A Study of BIIB067When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dis ...	A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-L ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Name: nd Product Code: [BIIB067(ISIS666853)] INN or Proposed INN: tofersen Other descriptive na ...	BIOGEN IDEC RESEARCH LIMITED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;Russian Federation;United Kingdom;Italy;France;Canada;Brazil;Belgium;Poland;Aust ...
2	EUCTR2020-004590-51-DE (EUCTR)	15/09/2021	19/03/2021	A Study of BIIB067When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dis ...	A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-L ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;Russian Federation;United Kingdom;Italy;France;Canada;Brazil;Belgium;Poland;Aust ...
3	EUCTR2016-003225-41-ES (EUCTR)	28/06/2021	14/06/2021	Long-Term Evaluation of BIIB067	An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Dis ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: Tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	183	Phase 3	United States;Spain;Israel;United Kingdom;European Union;Canada;Belgium;Poland;Australia;Denmark;Ger ...
4	EUCTR2020-004590-51-FR (EUCTR)	03/06/2021	01/04/2021	A Study of BIIB067When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dis ...	A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-L ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;Russian Federation;United Kingdom;Italy;France;Canada;Brazil;Belgium;Poland;Aust ...
5	EUCTR2020-004590-51-ES (EUCTR)	17/05/2021	01/09/2021	A Study of BIIB067When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dis ...	A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-L ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: Tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;Spain;Russian Federation;United Kingdom;Italy;France;Canada;Poland;Brazil;Belgium;Aust ...
6	NCT04856982 (ClinicalTrials.gov)	May 17, 2021	20/4/2021	A Study of BIIB067When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dis ...	A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-L ...	Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation	Drug: BIIB067 (Tofersen);Drug: Placebo	Biogen	NULL	Recruiting	18 Years	N/A	All	150	Phase 3	United States;Australia;Belgium;Brazil;Canada;France;Germany;Italy;Japan;Korea, Republic of;Poland;S ...
7	EUCTR2016-003225-41-DK (EUCTR)	16/12/2020	09/06/2020	Long-Term Evaluation of BIIB067	An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Dis ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: Tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	183	Phase 3	United States;Spain;Israel;Italy;United Kingdom;European Union;Canada;Belgium;Poland;Denmark;Austral ...
8	EUCTR2016-003225-41-PL (EUCTR)	01/12/2020	22/07/2020	Long-Term Evaluation of BIIB067	An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Dis ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: - Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	183	Phase 3	United States;European Union;Canada;Argentina;Belgium;Poland;Denmark;Australia;Germany;United Kingdo ...
9	EUCTR2015-004098-33-PL (EUCTR)	18/11/2020	10/07/2020	An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067in Adults W ...	A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BII ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	183	Phase 3	United States;Italy;United Kingdom;France;Canada;Argentina;Poland;Belgium;Australia;Denmark;Germany; ...
10	EUCTR2015-004098-33-DK (EUCTR)	23/03/2020	02/03/2020	An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067in Adults W ...	A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BII ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10077024;Term ...	Product Code: BIIB067 (ISIS666853) INN or Proposed INN: Tofersen Other descriptive name: BIIB067	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	183	Phase 1;Phase 2;Phase 3	France;United States;Canada;Poland;Belgium;Australia;Denmark;Germany;United Kingdom;Italy;Japan;Swed ...

First Previous1 2Next Last